Ataluren Impurity
|
|
775304-64-8
|
Ataluren Impurity
|
阿塔魯倫雜質(zhì)11
|
2786607-23-4
|
Omeprazole Impurity
|
奧美拉唑 N-氧化物
|
176219-04-8
|
Granisetron Impurity
|
向內(nèi)-N-(9-甲基-9-氮雜雙環(huán)[3.3.1]壬烷-3基)-1-甲基-1H-吲唑-3-甲酰胺
|
160177-67-3
|
Budesonide Impurity
|
布地奈德雜質(zhì)C
|
1040085-99-1
|
Eltrombopag Impurity
|
艾曲波帕甲酯
|
1246929-01-0
|
Budesonide Impurity
|
布地奈德EP雜質(zhì)J
|
313474-59-8
|
Ceftaroline Impurity
|
頭孢洛林酯雜質(zhì)5
|
953037-71-3
|
Bisoprolol Impurity
|
比索洛爾EP雜質(zhì)N
|
1346601-75-9
|
Budesonide
|
布地奈德
|
51333-22-3
|
Budesonide Impurity
|
脫氧強(qiáng)的松龍-16-烯
|
3103-17-1
|
Dotinurad Impurity
|
3,5-二氯-4-羥基苯甲酸
|
3336-41-2
|
5-Chloro-2-fluoronicotinic acid
|
5-氯-2-氟煙酸
|
884494-57-9
|
Canagliflozin Hydroperoxide Impurity
|
卡格列凈過氧化氫雜質(zhì)
|
2247196-28-5
|
Naltrexone Impurity
|
納曲酮EP雜質(zhì)I
|
96445-14-6
|
Betahistine Impurity
|
2-(2-氨乙基)吡啶
|
2706-56-1
|
Betahistine Impurity
|
2-吡啶乙醛
|
54765-14-9
|
Budesonide Impurity
|
布地奈德EP雜質(zhì)E
|
131918-64-4
|
Budesonide Impurity
|
布地奈德雜質(zhì)D
|
85234-63-5
|
Rasagiline Impurity
|
N-芐基酞酰亞胺
|
2142-01-0
|
Methyl tricosanoate
|
二十三酸甲酯
|
2433-97-8
|
Crisaborole Impurity
|
2-[(1,3-DIHYDRO-1-HYDROXY-2,1-BENZOXABOROL-5-YL)OXY]BENZONITRILE
|
906673-30-1
|
Budesonide Impurity
|
布地奈德雜質(zhì)13
|
2408495-96-3
|
Vonoprazan Impurity
|
沃諾拉贊雜質(zhì)171
|
2932441-73-9
|
Rasagiline Impurity
|
二炔丙胺
|
6921-28-4
|
Budesonide Impurity
|
布地奈德EP雜質(zhì)B
|
1040085-98-0
|
Budesonide Impurity
|
布地奈德雜質(zhì)5
|
131918-72-4
|
Apremilast Impurity
|
Apremilast Impurity 4
|
1831833-38-5
|
Phenylephrine ImpurityCl( (R-Isomer))
|
(+)-去甲苯福林鹽酸鹽
|
636-87-3
|
Granisetron Impurity
|
1-甲基-3-吲唑甲酸
|
50890-83-0
|
Budesonide Impurity
|
地索奈德
|
638-94-8
|
Isavuconazole Impurity
|
艾沙康唑雜質(zhì)96
|
1966991-73-0
|
Budesonide Impurity
|
[2-[(8S,9S,10R,11S,13S,14S)-11-羥基-10,13-二甲基-3-氧代-6,7,8,9,11,12,14,15-八氫環(huán)戊烯并[A]菲-17-基]-2-氧代乙基]乙酸酯
|
3044-42-6
|
Dapagliflozin Impurity
|
D-葡萄糖酸-γ-內(nèi)酯
|
1198-69-2
|
Naltrexone Impurity
|
納曲酮EP雜質(zhì)J
|
16617-07-5
|
Naltrexone Impurity
|
納曲酮雜質(zhì)
|
96445-13-5
|
Fexofenadine Impurity
|
非索非那定EP雜質(zhì)C
|
185066-37-9
|
Budesonide Impurity
|
布地奈德EP雜質(zhì)H
|
313474-58-7
|
Budesonide Impurity
|
布地奈德EP雜質(zhì)I
|
113930-13-5
|
Naltrexone Impurity
|
納曲酮EP雜質(zhì)H
|
503090-99-1
|
Olopatadine Impurity
|
伊索克酸
|
55453-87-7
|
Tedizolid Impurity
|
5-iodo-2-(2-methyl-2H-tetrazol-5-yl)pyridine
|
2095840-86-9
|
Nintedanib Impurity
|
Nintedanib Impurity 52
|
2410284-89-6
|
Naltrexone EP Impurity F
|
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,10,14-trihydroxy-, (5α,10α)-
|
2397651-97-5
|
Darolutamide Impurity
|
達(dá)洛魯胺雜質(zhì)4
|
2407645-49-0
|
Metoprolol USP Impurity
|
美托洛爾相關(guān)物質(zhì)B
|
56718-76-4
|
Vildagliptin carboxylic acid Impurity
|
維格列汀羧酸
|
565453-40-9
|
Fexofenadine Impurity
|
4-((4-(4-羥基二苯甲基)-1-哌啶基)-1-氧代丁基)-A,A-二甲基苯乙酸
|
76811-98-8
|
Granisetron Impurity
|
1-Methyl-1H-indazole-3-carboxaMide
|
129137-93-5
|
Pitavastatin (3S,5S)-Isomer Calcium
|
(3S, 5S)-匹伐他汀鈣鹽
|
254452-92-1
|
Darolutamide Impurity
|
(S)-4-(1-(2-氨基丙基)-1H-吡唑-3-基)-2-氯苯甲腈
|
1297537-41-7
|
Cinacalcet Impurity
|
西那卡塞雜質(zhì)87 鹽酸鹽
|
2469242-96-2
|
Esomeprazole Impurity
|
奧美拉唑硫醚
|
73590-85-9
|
Fexofenadine Impurity
|
非索非那定相關(guān)物質(zhì)B
|
479035-75-1
|
Naltrexone Impurity
|
(5ALPHA)-4,5-環(huán)氧-3,14-二羥基-6-氧代嗎喃-17-甲醛
|
1007856-83-8
|
Dapoxetine Impurity 12
|
達(dá)泊西汀雜質(zhì)
|
2242008-38-2
|
Budesonide Impurity
|
布地奈德雜質(zhì)11
|
39672-76-9
|
Rasagiline Impurity
|
雷沙吉蘭雜質(zhì)8
|
92850-02-7
|
Indapamide Impurity
|
脫氫吲達(dá)帕胺
|
63968-75-2
|
Granisetron Impurity
|
格拉司瓊相關(guān)物質(zhì)A
|
127472-42-8
|
Ticagrelor Impurity
|
替格瑞洛雜質(zhì)J
|
2096989-55-6
|
Budesonide Impurity
|
DELTACORTINENE ACETATE (PREDISOLONE ACETATE IMPURITY)
|
4380-55-6
|
Pitavastatin Impurity
|
(3R, 5R)-匹伐他汀鈣鹽
|
254452-96-5
|
7,8-Didehydronaltrexone
|
納曲酮雜質(zhì)11
|
123086-68-0
|
2,4,6-trimethoxy-1,3,5-triazine
|
三聚氰酸三甲酯
|
877-89-4
|
Thymol
|
麝香草酚
|
89-83-8
|
Tenofovir Impurity
|
氯甲基乙基碳酸酯
|
35179-98-7
|
Dotinurad Impurity
|
多替諾德雜質(zhì)6
|
1285573-44-5
|
Metoprolol Impurity
|
{[4-(2-甲氧乙基)苯氧基]甲基}環(huán)氧乙烷
|
56718-70-8
|
Ataluren Impurity
|
阿塔魯倫雜質(zhì)12
|
1807701-53-6
|
Budesonide Impurity
|
布地奈德雜質(zhì)
|
192057-49-1
|
4-chloro-N1-methylbenzene-1,2-diamine
|
4-氯-N1-甲基苯-2-胺
|
59681-66-2
|
Azithromycin Impurity
|
阿奇霉素雜質(zhì)P
|
92594-45-1
|
Naloxone Impurity
|
納洛酮雜質(zhì)1
|
70866-64-7
|
2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate
|
2 3 4 6-四-O-乙酰-BETA-吡喃葡萄糖
|
14152-97-7
|
Budesonide Impurity
|
16alpha-羥基潑尼松龍
|
13951-70-7
|
Indapamide Impurity
|
4-氯-3-磺酰胺基苯甲酸
|
1205-30-7
|
Darolutamide Impurity
|
5-(1-Hydroxyethyl)-1H-pyrazole-3-carboxylic acid
|
1401584-94-8
|
Apremilast Impurity
|
阿普斯特雜質(zhì)26
|
2733250-84-3
|
1,2Dimethylbenzimidazole
|
1,2-二甲基苯并咪唑
|
2876-08-6
|
Febuxostat Impurity
|
非布司他/非布索坦雜質(zhì)123
|
2476465-06-0
|
Budesonide Impurity
|
布地奈德雜質(zhì)K
|
51333-05-2
|
Rosuvastatin Methyl Intermediate Impurity
|
(Intermediates of Rosuvastatin Calcium R-4
|
851440-19-2
|
Letermovir Impurity
|
917389-29-8
|
917389-29-8
|
Ceftaroline Impurity
|
CEFTAROLINE中間體
|
1427207-46-2
|
Naltrexone Impurity
|
納曲酮EP雜質(zhì)E
|
767615-69-0
|
Budesonide Impurity
|
布地奈德雜質(zhì)6
|
131918-73-5
|
Omeprazole Impurity
|
奧美拉唑雜質(zhì)A
|
88546-55-8
|
Granisetron Impurity
|
向內(nèi)-N-(9-甲基-9-氮雜雙環(huán)[3.3.1]壬烷-3基)-1H-吲唑-3-甲酰胺
|
107007-95-4
|
Budesonide Impurity
|
21-羥基孕甾-1,4,9(11),16-四烯-3,20-二酮-21-醋酸酯
|
37413-91-5
|
Ilaprazole Impurity
|
艾普拉唑雜質(zhì)34
|
2285351-50-8
|
Naltrexone Impurity
|
納曲酮雜質(zhì)
|
607732-61-6
|
Ceftaroline Impurity
|
頭孢羅膦
|
400827-55-6
|
Budesonide Impurity
|
布地奈德雜質(zhì)L
|
216453-74-6
|
Ceftaroline Impurity
|
頭孢洛林雜質(zhì) 3
|
1286218-63-0
|
Ceftaroline Impurity
|
頭孢洛林雜質(zhì)B
|
1240196-56-8
|
Lurasidone Impurity
|
魯拉西酮雜質(zhì)3
|
1448443-35-3
|
Ilaprazole Impurity
|
艾普拉唑雜質(zhì)21
|
2285346-38-3
|
Formamide
|
甲酰胺
|
75-12-7
|
Tranexamic Acid Impurity
|
氨甲環(huán)酸二聚體
|
93940-19-3
|